These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
344 related items for PubMed ID: 10722430
1. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, Von Gottberg A, Mohapatra S, Trenholme GM, Klugman KP, McCormack JG, Yu VL. Clin Infect Dis; 2000 Mar; 30(3):473-8. PubMed ID: 10722430 [Abstract] [Full Text] [Related]
2. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study. Mosqueda-Gómez JL, Montaño-Loza A, Rolón AL, Cervantes C, Bobadilla-del-Valle JM, Silva-Sánchez J, Garza-Ramos U, Villasís-Keever A, Galindo-Fraga A, Palacios GM, Ponce-de-León A, Sifuentes-Osornio J. Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321 [Abstract] [Full Text] [Related]
8. Nosocomial bacteremia and urinary tract infections caused by extended-spectrum beta -lactamase-producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes. Alcantar-Curiel D, Tinoco JC, Gayosso C, Carlos A, Daza C, Perez-Prado MC, Salcido L, Santos JI, Alpuche-Aranda CM. Clin Infect Dis; 2004 Apr 15; 38(8):1067-74. PubMed ID: 15095209 [Abstract] [Full Text] [Related]
9. Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal. Mendonça N, Ferreira E, Louro D, ARSIP Participants, Caniça M. Int J Antimicrob Agents; 2009 Jul 15; 34(1):29-37. PubMed ID: 19272757 [Abstract] [Full Text] [Related]
10. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. Antimicrob Agents Chemother; 2004 Dec 15; 48(12):4574-81. PubMed ID: 15561828 [Abstract] [Full Text] [Related]
11. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia. Lee CI, Lee NY, Yan JJ, Lee HC, Ko NY, Chang CM, Wu CJ, Chen PL, Wang LR, Ko WC. J Microbiol Immunol Infect; 2009 Aug 15; 42(4):303-9. PubMed ID: 19949753 [Abstract] [Full Text] [Related]
12. [Short communication: Extended-spectrum beta-lactamase production in Klebsiella pneumoniae strains isolated from blood cultures and their antibiotic susceptibilities]. Işik F, Arslan U, Tuncer I. Mikrobiyol Bul; 2008 Jan 15; 42(1):131-6. PubMed ID: 18444571 [Abstract] [Full Text] [Related]
13. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae. Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB, Kim EC, Oh MD, Choe KW. Antimicrob Agents Chemother; 2004 Oct 15; 48(10):3720-8. PubMed ID: 15388426 [Abstract] [Full Text] [Related]
14. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in paediatric wards: a nested case-control study. Demir S, Soysal A, Bakir M, Kaufmann ME, Yagci A. J Paediatr Child Health; 2008 Oct 15; 44(10):548-53. PubMed ID: 18557808 [Abstract] [Full Text] [Related]